发明名称 Serine protease inhibitors
摘要 A process for the preparation of compounds of formula (I) <CHEM> in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, which are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders, and intermediates useful in the preparation of the compounds.
申请公布号 AU2001262553(B2) 申请公布日期 2006.07.06
申请号 AU20010262553 申请日期 2001.06.12
申请人 ELI LILLY AND COMPANY 发明人 MICHAEL JOHN MAYER;BRIAN MORGAN WATSON;NICHOLAS PAUL CAMP;STEPHEN CLINTON YOUNG;MICHAEL ROBERT WILEY;PETER ROBERT GUZZO;STUART DONALD JONES;CHRISTOPHER WILLIAM MURRAY;SCOTT MARTIN SHEEHAN;JOHN WALTER LIEBESCHUETZ;WILLIAM ALEXANDER WYLIE;DAVID BIRENBAUM ENGEL;JOHN JOSEPH MASTERS
分类号 C07D295/16;C07D295/18;A61K31/395;A61K31/445;A61K31/495;A61K31/496;A61K31/497;A61K31/501;A61P1/16;A61P7/02;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P17/02;A61P19/02;A61P29/00;A61P35/00;A61P43/00;C07D207/12;C07D207/14;C07D211/26;C07D211/46;C07D211/58;C07D213/36;C07D213/38;C07D213/56;C07D213/74;C07D231/56;C07D277/64;C07D295/185;C07D309/14;C07D309/32;C07D309/34;C07D335/02;C07D401/12;C07D401/14;C07D403/12;C07D409/12;C07D417/12;C07D417/14;C07D521/00 主分类号 C07D295/16
代理机构 代理人
主权项
地址